Welcome to my nightmare, this is one of the most confusing one day charts I have looked at in quite a while. From afar, the larger counts look like a 4th wave, but the micro count is a REAL mess, almost like an on going "B", or "X" wave, the triangle I have labeled as a-b-c-d-e, breaks the first rule, wave "A", is a five count, we need a 3-3-3-3-3 count for the triangle to be valid.
A simple zig-zag is still possible, but wave "C" needs to be the largest for that count to work.
The other possibility is that we have had a top put in, I have seen numerous counts in the last 24 hours that have a five wave count completed, the micro-counts in them might be off, but at this point I am keeping that option on the table until the impulse count from 1037.63 is invalidated.
One other option, which I had a chart up of yesterday on my public list, is this whole rally counting out as an a-b-c-x-a-b-c, making wave b of B, of P2, an expanding triangle with the a of B ending at 979. This could really surprise the bears if we start heading down to make new lows, then quickly reverse in wave "C" up.
See Michael’s longer term chart (below) for the bigger picture:
Michael: P stands for primary wave. As soon as P2 ends, we will be in P3, down. P2 is the wave from 666 to the present, P1 was the wave from late ’07, till this year when it finished at 666. Ilene, I am very-very bearish, as soon as this rally is over we will be testing the lows of the year, and even quite possibily breaking them, wave 3′s are the mother of all waves, very violent and swift.
Not sure if that is any better then Monday morning quarterbacking. I brought this one out of my vault of super-secret and private stash of charts that only Anchak has laid eyes on. This one came about from the both of us playing with different indicators and tweaking them to get the most out of them. The one that caught my eye this morning was the RSI, adjusted just right, it has been a good and reliable indicator for showing trend changes in the SPX, by following the changes of trends in itself. Unbelievable how over-bought it has gotten in the last month, and now showing a definite trend change to the down side. When you couple the RSI with the MACD, and the Histogram, things are starting to point to a change coming soon, if it has not already changed. The Histogram has been in a negative divergence for the last month, and has its first red shoot, breaking below zero last week, while at the same time the MACD has also turned to the downside and crossed over, peaking last week. The MACD, a lagging indicator (used together with the histogram it can be used as a leading indicator) also showing a change is taking place. I am not ready to officially call that the top, I will leave it to you to make your own decisions. I am just sharing my Sunday morning thoughts with you. Hope you are enjoying your week-end!!
PS.-I moved this chart to the public list if you are interested in following it
I wanted to do a quick update and highlight the 60-minute SP500 intraday chart from the March lows to the June highs and overlay four Fibonacci grids over this move to uncover the hidden confluence zones. Doing so allows us to see why the recent break beneath 880 is perhaps very significant.
(Click image for full-size graph)
Without getting too complex, I’ve drawn four Fibonacci Retracement grids from the March lows to the June 11th highs using the classic methods.
I’m using the standard 38.2%, 50.0%, and 61.8% retracements, but also adding the lesser-known 23.6% and 78.6% retracements as well. I drew vertical lines to show where the grids originated.
The main point is that three of the four grids ‘converge’ at the 890 level (I’ve highlighted it). Notice how this area provided very strong support (in fact, it helped create the current “Head and Shoulders” since May.
Experience is never limited, and it is never complete; it is an immense sensibility, a kind of huge spider-web of the finest silken threads suspended in the chamber of consciousness, and catching every air-borne particle in its tissue.
The 120-minute SPX chart above shows a clustering of Wave 5′s (various degrees), followed by a breakdown of the Up-Trend Regression Channels and a Blue Wave Sell Signal, all taking place since last’s Thursday’s close.
The above chart the SPX pans out to the Daily perspective and reveals a rounding top that is just barely holding onto an 11-day-old Blue Wave Buy Signal that did flip to Short on an Intraday basis today, before those mysterious institutional buy programs again propped up a weakening close.
Finally, the above is a Weekly chart that is about as long in the tooth as it can be.
I want that Weekly trend regression channel broken to the downside and/or a Blue Wave Sell Signal before committing a total and immense sensibility to the Short sideof this market.
Back in 1992, Democratic strategist James Carville uttered his famous recommendation to Bill Clinton ahead of the 1992 election: “It’s the economy, stupid!” Political scientists beat Carville to the punch, though: As far back as the 1950’s, scho...
The euro "might start to unravel" if Deutsche Bank collapses according to respected financial journalist Matthew Lynn. "It all has a very 2008 feel to it ..." he warns in the Telegraph where he outlines his growing concerns about Deutsche Bank, concerns we have written about in recent months. He writes:
Howard Marks, co-chairman at Oaktree Capital Group, discusses how clients are approaching the current market, investors continuing to act bullish, and fighting the idea of going to cash. He speaks with Bloomberg’s Erik Schatzker on “Bloomberg Markets” and also appears at the Bloomberg Markets Most Influential Summit in New York. (Source: Bloomberg)
A decision by the U.S. Securities and Exchange Commission may bring European Union banks a step closer to avoiding billions of dollars of capital charges on their trades in derivatives and other securities.
In early 2009, the seven largest publicly traded college operators were worth a combined $51 billion. Today, they’ve been all but wiped out.
When Barack Obama took office, America’s seven largest publicly traded college operators were worth a combined $51 billion, with more than 815,000 students enrolled at campuses spread across the country. The schools were flooded with with people seeking shelter from the recession, returning to school to pick up new skills.
Almost eight years later, the industry has been decimated. The seven largest listed operators are worth just over $6 billion, and the most valuable co...
Reminder: OpTrader is available to chat with Members, comments are found below each post.
This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).
We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options.
Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.
To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here
I was so pleased yesterday by the announcement that I have joined the Research team at GoldCore as it meant that I could finally start talking about it and was back in a role that lets me indulge in my passion by researching and geeking out on all things gold, silver and money.
Reminder: Pharmboy is available to chat with Members, comments are found below each post.
Epizyme was founded in 2007, and trying to create drugs to treat patient's cancer by focusing on genetically-linked differences between normal and cancer cells. Cancer areas of focus include leukemia, Non-Hodgkin's lymphoma and breast cancer. One of the Epizme cofounders, H. Robert Horvitz, won the Nobel Prize in Medicine in 2002 for "discoveries concerning genetic regulation of organ development and programmed cell death."
Before discussing the drug targets of Epizyme, understanding epigenetics is crucial to comprehend the company's goals.
Genetic components are the DNA sequences that are 'inherited.' Some of these genes are stronger than others in their expression (e.g., eye color). Yet, some genes turn on or off due to external factors (environmental), and it is und...
Note: The material presented in this commentary is provided for
informational purposes only and is based upon information that is
considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW)
nor its affiliates
warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.
Site owned and operated by PSW Investments, LLC. Contact us at: 403 Central Avenue, Hawthorne, NJ 07506. Phone: (201) 743-8009. Email: firstname.lastname@example.org.